ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 744,72
0,03%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. 89bio Inc (ETNB)

  7. 89bio Inc (ETNB) Actualités

ETNB

89bio (ETNB)

89bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ETNB
DateHeureSourceTitreSymboleSociété
31/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ETNB89bio Inc
09/05/202422h45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ETNB89bio Inc
01/03/202423h06Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:ETNB89bio Inc
01/03/202423h03Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ETNB89bio Inc
24/02/202402h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ETNB89bio Inc
14/02/202417h32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ETNB89bio Inc
08/12/202312h08Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ETNB89bio Inc
21/09/202315h07Dow Jones News89bio Gets FDA Breakthrough Designation for Pegozafermin in NASHNASDAQ:ETNB89bio Inc
09/06/202322h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETNB89bio Inc
07/06/202323h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETNB89bio Inc
05/06/202323h35Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ETNB89bio Inc
25/04/202323h29Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:ETNB89bio Inc
24/04/202322h36Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ETNB89bio Inc
24/04/202322h34Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ETNB89bio Inc
24/03/202312h00GlobeNewswire Inc.89bio, Inc. Announces Upsized Pricing of $275 Million Public Offering of Common StockNASDAQ:ETNB89bio Inc
22/03/202322h06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ETNB89bio Inc
22/03/202321h16GlobeNewswire Inc.89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:ETNB89bio Inc
15/03/202312h06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ETNB89bio Inc
15/03/202311h25Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ETNB89bio Inc
14/02/202323h25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ETNB89bio Inc
14/02/202323h17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ETNB89bio Inc
14/02/202322h33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ETNB89bio Inc
10/02/202322h04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:ETNB89bio Inc
31/01/202312h08Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ETNB89bio Inc
04/01/202322h01GlobeNewswire Inc.89bio Provides Business Update and Outlook for 2023NASDAQ:ETNB89bio Inc
13/12/202200h30GlobeNewswire Inc.89bio Announces Publication of Results of Phase 1b/2a Study of Pegozafermin for the Treatment of NASH in The Lancet Gastroenterology & HepatologyNASDAQ:ETNB89bio Inc
25/11/202210h04TipRanksAnalysts Say These 2 ‘Strong Buy’ Stocks Are Their Top Picks for 2023NASDAQ:ETNB89bio Inc
21/11/202212h21TipRanksAnalysts Offer Insights on Healthcare Companies: Altimmune (ALT), 89bio (ETNB) and Avadel Pharmaceuticals (AVDL)NASDAQ:ETNB89bio Inc
14/11/202205h05TipRanksBTIG Sticks to Its Buy Rating for 89bio (ETNB)NASDAQ:ETNB89bio Inc
14/11/202204h57TipRanks89bio (ETNB) Receives a Buy from SVB SecuritiesNASDAQ:ETNB89bio Inc
 Showing the most relevant articles for your search:NASDAQ:ETNB

Dernières Valeurs Consultées

EU
BN
Danone
COIN
ETHUSD
Ethereum
EU
ORA
Orange
NASDAQ
AMZN
Amazon.com
EU
AF
Air FranceKLM
USI
USTECH100
US Tech 100
EU
AI
Air Liquide
EU
VK
Vallourec
NYSE
MRK
Merck
EU
ACA
Credit Agricole
EU
GLE
Societe Generale
EU
SGO
Cie de SaintGobain
EU
RI
Pernod Ricard
FTSE
UKX
FTSE 100
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés